Pss40 - Cost-Effectiveness of Ocriplasmin for the Treatment of Vitreomacular Traction, Including When Associated With Macular Hole: A Belgian Perspective

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2540
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Ocriplasmin for Treatment of Vitreomacular Traction: An Update

Ophthalmology and Therapy
Ophthalmology
2016English

Pss26 - Cost Effectiveness of Ocriplasmin for Treatment of Symptomatic Vitreomacular Adhesion in the United States

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Ocriplasmin for the Treatment of Vitreomacular Traction and Macular Holes: Long-Term Modelling of Clinical and Economic Value of Resolution of Traction in France

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

Unusual Macular Retinal Detachment Associated With Vitreomacular Traction Syndrome

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
1998English

Ocriplasmin Treatment for Vitreomacular Traction in Real Life: Can the Indication Spectrum Be Expanded?

Acta Ophthalmologica
MedicineOphthalmology
2017English

Pars Plana Vitrectomy for Treatment-Naïve Diabetic Macular Edema With or Without Vitreomacular Traction

Canadian Journal of Ophthalmology
MedicineOphthalmology
2018English

Vitrectomy Outcomes in Eyes With Diabetic Macular Edema and Vitreomacular Traction

Ophthalmology
Ophthalmology
2010English

Vitreomacular Traction

2016English

Vitreomacular Traction Affects Anti-Vascular Endothelial Growth Factor Treatment Outcomes for Exudative Age-Related Macular Degeneration

Retina
MedicineOphthalmology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy